Thanks a ton for commenting on this.
Absolutely very happy to see you all coming in.
Now, please take a look at the other thread I made about this
https://www.longecit...ood-old-line-1/
I am trying to explain in the thread above how this all ties in so well with what David Sinclair is saying. To me this all can be summed up as follows:
Line-1 is nothing but trouble. It helps us not at all (at least on an individual level; may have helped the species)
Its expression is kept under control through SIRT6. When we get old, for reasons I kind of understand but cannot elaborate on since I am not confident of my grasp thereof, SIRT6 gets inefficient in suppressing Line-1
Line-1 then gets out of control and aging as well as cancer ensue.
1- QuestforLife, can you please explain how Line-1 helps the rapid cell division at the embryo stage?
2- I thought it was simply the inability of SIRT6 to suppress Line-1 that marks the tipping point in the system. You guys spoke extensively of telomeres, however. Can you please explain how telomeres play a role here? Is is that shorter telomeres --> loss of SIRT 6 function?
3- Of course we want to think of as many angles of attack as possible, but why not focus on the specific drug that has been proposed and also studied for reducing the activity of Line-1 retrotransposition? i.e. Lamivudine
check this out
https://sci-hub.tw/h...met.2019.02.014
Yes, Lamivudine does have side effects, but when treating AIDS patients with this drug (it is an HIV medicine), they target the reduction of HIV load to undetectable levels. We do not need such aggressive suppression of reverse transcription activity. Can we not use a low-ish dose for an extended period?
I do not want to trivialize this drug, but when I read the side effects, most seem not so terrible (I am emphasizing "most")
thanks again